NWBO - Northwest Biotherapeutics reports Q1 results June, 24 2020 03:35 PM Northwest Biotherapeutics Inc. Northwest Biotherapeutics (OTCQB:NWBO): Q1 GAAP EPS of $0.00.Revenue of $0.57M (+67.6% Y/Y)Press ReleaseMore news on: Northwest Biotherapeutics, Inc., Earnings news and commentary, Healthcare stocks news,